Date
2020-02-26
Time:
1800 UTC
1000 PST
Zoom Meeting Details
Topic: SNOMED EAG Conference Call
Time: Feb 26, 2020 10:00 AM Pacific Time (US and Canada)
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/3306923098
Attendees
Chair:
AG Members
Invitees:
Observers
Apologies:
Meeting Files:
Meeting minutes:
The call recording is located here.
The edited transcript is located here.
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Call to order and role call | Start recording! |
| |
2 | Conflicts of interest and agenda review | |||
3 | Diet findings vs. Diet regimes | A proposal to replace many of the diet finding terms (e.g. high fat diet) with regime/therapy concepts has run into an obstacle with the current usage within the UKTC where these terms originated. In consultation with the UKTC, it has been proposed that we:
Discussion: | ||
4 | Replacement of substance with Product in Adverse reactions | A question regarding "Adverse reaction" CAUSATIVE AGENT. The work group has determined that these concepts should have the CAUSATIVE AGENT replaced with "Product" concepts. Is this a substantive change that requires inactivation and replacement? Estimated number of concepts ≈1500-2000 concepts. Discussion: | ||
5 | Evaluation procedures vs. Observable entity | Daniel Karlsson | Propose way forward to address the apparent duplication between these two hierarchies:
Discussion: | |
6 | Technique hierarchy issues | Daniel Karlsson | Evaluation procedures with an observation technique (e.g. ELISA) are often primitives with a few distinct techniques in the 129264002 | Action (qualifier value) | hierarchy (particularly the Imaging – actions). Observable entity has a technique attribute whereas evaluation procedures have none (with an overlap with some actions). Moving eval procedures to observables would possibly require being explicit about the technique. Discussion: | |
7 | Additional description types | Jim Case | As discussed in KL. Need a list of proposed description types to send to tech services for implementation. Guidance on use will need to be developed. Current use cases to consider are:
Issues within our current synonyms was identified in an AMIA paper in 2003: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480077/pdf/amia2003_0949.pdf Discussion: | |
8 | ECE Update | Bruce Goldberg |
Discussion: | |
9 | Concept inactivation project group | Paul Amos | Update from work group Discussion: | |
10 | Morphology (disorder) concepts | Jim Case | SNOMED CT currently has a large number of disorder concepts that solely represent morphologies. E.g. 416462003 |Wound (disorder)|; 416439000 |Lipogranuloma (disorder)|). While all of these are SD by simply using DIsease + morphology, other than as grouping concepts, are these valuable clinical terms. With the advent of ECL it is a simple query to identify all concepts that fit into these morphologies. What should be the editorial guidance for the creation/maintenance of these terms? | |
11 | Next meeting | EAG | April business meeting in London |